Tempus AI (NASDAQ:TEM) Trading Down 4.4% After Insider Selling

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) traded down 4.4% during mid-day trading on Friday following insider selling activity. The stock traded as low as $71.50 and last traded at $73.34. 5,496,515 shares were traded during trading, a decline of 61% from the average session volume of 14,108,693 shares. The stock had previously closed at $76.72.

Specifically, CFO James William Rogers sold 31,780 shares of the firm's stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $82.33, for a total value of $2,616,447.40. Following the sale, the chief financial officer now owns 189,320 shares in the company, valued at approximately $15,586,715.60. This trade represents a 14.37 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Erik Phelps sold 61,582 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $82.36, for a total value of $5,071,893.52. Following the completion of the transaction, the executive vice president now directly owns 153,080 shares in the company, valued at approximately $12,607,668.80. This represents a 28.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In other news, CAO Ryan M. Bartolucci sold 818 shares of the business's stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $81.87, for a total value of $66,969.66. Following the transaction, the chief accounting officer now owns 46,182 shares of the company's stock, valued at approximately $3,780,920.34. The trade was a 1.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Analyst Ratings Changes

TEM has been the subject of a number of recent research reports. Stifel Nicolaus lowered shares of Tempus AI from a "buy" rating to a "hold" rating and raised their target price for the company from $45.00 to $65.00 in a report on Monday, November 11th. Guggenheim initiated coverage on Tempus AI in a research report on Monday, December 9th. They issued a "buy" rating and a $74.00 price target for the company. Piper Sandler restated a "neutral" rating and set a $70.00 price objective (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. William Blair downgraded shares of Tempus AI from an "outperform" rating to a "market perform" rating in a research note on Wednesday, February 12th. Finally, Wolfe Research began coverage on shares of Tempus AI in a research note on Friday, December 13th. They set an "outperform" rating and a $60.00 price target for the company. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to MarketBeat.com, Tempus AI currently has a consensus rating of "Moderate Buy" and an average target price of $58.55.

Tempus AI Trading Up 2.2 %

The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The firm has a fifty day simple moving average of $50.29 and a 200 day simple moving average of $51.82.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings data on Monday, February 24th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.15) by ($0.18). On average, equities research analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Operose Advisors LLC purchased a new position in Tempus AI in the fourth quarter valued at about $25,000. First Horizon Advisors Inc. purchased a new position in shares of Tempus AI in the 3rd quarter worth approximately $30,000. Farther Finance Advisors LLC bought a new position in shares of Tempus AI during the 4th quarter worth approximately $34,000. Prestige Wealth Management Group LLC lifted its position in Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock valued at $36,000 after acquiring an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC purchased a new position in Tempus AI in the fourth quarter worth $49,000. 24.22% of the stock is owned by institutional investors.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.